News
Is it time for universal genetic testing in colorectal cancer?
- Author:
- Mark L. Fuerst
Publish date: April 26, 2021
News
SNP chips deemed ‘extremely unreliable’ for identifying rare variants
- Author:
- Mark L. Fuerst
Publish date: March 17, 2021
Article
ASCO, CSCO outline ‘best practices’ for nasopharyngeal carcinoma
- Author:
- Mark L. Fuerst
Publish date: March 10, 2021
News
ASCO announces new advanced liver cancer guidelines
- Author:
- Mark L. Fuerst
Publish date: February 22, 2021
News
Model could reduce some disparities in lung cancer screening
- Author:
- Mark L. Fuerst
Publish date: February 10, 2021
News
Customized chemotherapy did not improve survival in early NSCLC
- Author:
- Mark L. Fuerst
Publish date: February 9, 2021
News
Cisplatin tops cetuximab for advanced head and neck cancer
- Author:
- Mark L. Fuerst
Publish date: February 9, 2021
News
Neoadjuvant atezolizumab safe for patients with resectable lung cancer
- Author:
- Mark L. Fuerst
Publish date: February 9, 2021
News
Sotorasib in NSCLC: ‘Historic milestone’ reached
- Author:
- Mark L. Fuerst
Publish date: February 8, 2021
News
Death rates ‘remain high’ in patients with thoracic cancers and COVID-19
- Author:
- Mark L. Fuerst
Publish date: February 4, 2021
News
Pandemic seems to impact lung cancer diagnosis and prognosis
- Author:
- Mark L. Fuerst
Publish date: February 2, 2021
News
Nulliparity, not ART, likely raises risk of ovarian cancer
- Author:
- Mark L. Fuerst
Publish date: January 19, 2021
News
Dexamethasone may ‘jeopardize’ benefit of immunotherapy in glioblastoma
- Author:
- Mark L. Fuerst
Publish date: December 23, 2020
News
Fear of recurrence highly prevalent in RCC survivors
- Author:
- Mark L. Fuerst
Publish date: December 4, 2020
News
Black patients with ES-SCLC get less chemo but have better survival
- Author:
- Mark L. Fuerst
Publish date: November 30, 2020